Actively Recruiting
Expressive Writing for the Management of Stress in Cancer Survivors
Led by M.D. Anderson Cancer Center · Updated on 2025-11-21
414
Participants Needed
1
Research Sites
438 weeks
Total Duration
On this page
Sponsors
M
M.D. Anderson Cancer Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This clinical trial evaluates the effect of expressive writing for the management of stress in cancer survivors. Cancer diagnosis and treatment are associated with increased stress in cancer survivors related to concerns about family, career, relationships, finances, side effects of treatment, and death. This stress can be further exacerbated by social upheavals such as the COVID-19 pandemic. For safety reasons, many patients are isolated with restricted access to in-person health care and reduced social interaction with family and friends. Together with the economic uncertainties that come with this pandemic, these factors are likely to increase cancer survivors' stress levels. Expressive writing may provide a medium through which cancer survivors confront stressors and find meaning in their experience. The goal of this trial is to learn more about the experiences of cancer survivors during stressful times.
CONDITIONS
Official Title
Expressive Writing for the Management of Stress in Cancer Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years old
- Have a diagnosis of cancer within the past 3 years
- Are able to speak and read in English
- Have access to a computer or smart phone with internet connection
- All disease sites and all cancer stages are eligible for enrollment
You will not qualify if you...
- Inability to provide informed consent
- Non-English speakers will be excluded because this is a feasibility study that will enroll only a limited number of participants
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
Q
Qian LU, MD,PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here